Trial Profile
The clinical study to examine efficacies of BSL5-170327C and BSL5-170327S on healthy skin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2017
Price :
$35
*
At a glance
- Drugs BSL5 170327C (Primary)
- Indications Skin disorders
- Focus Therapeutic Use
- Sponsors Kao Corporation
- 27 Oct 2017 Status changed from not yet recruiting to completed.
- 19 May 2017 New trial record